Isaac Klein, M.D., Ph.D.

Executive Officer at Dewpoint Therapeutics

Capital raised by Dewpoint Therapeutics

$77.2M+$77.2M latest round

1 Form D filing · first filed Sep 2025 · Boston, MA

CURRENT ROLE: Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: 3 ↗

Career

1 company on file

Dewpoint TherapeuticsBiotech · Boston, MAsince Sep 2025

Executive Officer

Listed on Dewpoint Therapeutics's Form D filings

Company filings

via EDGAR · Form D for Dewpoint Therapeutics1

DateCompanyFormAmountRole on filing

Sep 9, 2025Dewpoint TherapeuticsForm D/A+$77.2M—

Form D/ASep 9, 2025 · Dewpoint Therapeutics+$77.2Mnot a signer

Overview

Last filing Sep 9, 2025

Isaac Klein, M.D., Ph.D. is on file as Executive Officer at Dewpoint Therapeutics in Boston, MA. Dewpoint Therapeutics has 1 Form D filing on record, $77.2M raised in total.

Teammates

Dewpoint Therapeutics · 1

Ameet NathwaniPresident and Chief Executive OfficerSigner

Products

Dewpoint Therapeutics · 1

Condensate modulator (c-mod) pipelineClinical-stage small-molecule therapeutics

A portfolio of small-molecule condensate modulators discovered on the ERSAi platform, led by DPTX3186, a beta-catenin condensate modulator in Phase 1/2 for gastric cancer with FDA fast track and orphan drug designations, alongside an oral MYC modulator enrolling patients in solid tumors and a TDP-43 development candidate for ALS.